Litcius/Paper detail

Avoidance or adaptation of radiotherapy in patients with cancer with Li-Fraumeni and heritable TP53-related cancer syndromes

Juliette Thariat, François Chevalier, Daniel Orbach, Luc Ollivier, Pierre-Yves Marcy, Nadège Corradini, Arnaud Beddok, Nicolas Foray, Gaëlle Bougeard

2021The Lancet Oncology74 citationsDOIOpen Access PDF

Topics & Concepts

Li–Fraumeni syndromeCancerMedicineRadiation therapyAdaptation (eye)OncologyInternal medicineBiologyGeneticsMutationGermline mutationNeuroscienceGeneCancer-related Molecular PathwaysAdvanced Breast Cancer TherapiesHedgehog Signaling Pathway Studies
Avoidance or adaptation of radiotherapy in patients with cancer with Li-Fraumeni and heritable TP53-related cancer syndromes | Litcius